fda glp-1 compounding warning october 2025 US sends 25 letters to telehealth companies over claims on compounded weight-loss drugs Last month, the FDA issued

The total-cost frame: month one vs annualized Sticker price at month one is misleading because some programs quote a lower entry rate that steps up at refill

For patients new to GLP-1 therapy or those with sensitive systems, microdosing offers a gentler introduction

Worsening Diabetic Retinopathy: Rapid glucose lowering may exacerbate pre-existing eye conditions in some patients

FCPS: How will providers know when a deductible is met

Her expertise in both GLP1 medications and hormone therapy, combined with her holistic approach to womens health, provides the comprehensive care needed for successful menopause weight management